|
ACVR2B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.005000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.680200E-01 |
| Normal-vs-Stage2 |
4.539600E-01 |
| Normal-vs-Stage3 |
1.106180E-01 |
| Normal-vs-Stage4 |
3.710400E-01 |
| Stage1-vs-Stage2 |
4.358800E-01 |
| Stage1-vs-Stage3 |
3.917800E-02 |
| Stage1-vs-Stage4 |
4.046400E-01 |
| Stage2-vs-Stage3 |
4.175000E-01 |
| Stage2-vs-Stage4 |
8.219000E-01 |
| Stage3-vs-Stage4 |
6.786600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.667800E-01 |
| Normal-vs-AfricanAmerican |
8.700600E-01 |
| Normal-vs-Asian |
6.839400E-01 |
| Caucasian-vs-AfricanAmerican |
8.095400E-01 |
| Caucasian-vs-Asian |
8.690200E-01 |
| AfricanAmerican-vs-Asian |
8.704400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.661000E-01 |
| Normal-vs-Female |
3.878800E-01 |
| Male-vs-Female |
2.060200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.875000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.630400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.433200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.838410E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.520400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.671830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.770000E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.493200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.758880E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.784100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.655100E-03 |
| Classical-VS-Follicular |
4.035700E-04 |
| Classical-VS-Other |
8.284800E-01 |
| Classical-VS-Normal |
8.128400E-01 |
| Tall-VS-Follicular |
7.940800E-01 |
| Tall-VS-Other |
4.433600E-01 |
| Tall-VS-Normal |
5.031800E-02 |
| Follicular-VS-Other |
4.120800E-01 |
| Follicular-VS-Normal |
2.349800E-02 |
| Other-VS-Normal |
7.876000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.843400E-01 |
| Normal-vs-N1 |
3.914000E-01 |
| N0-vs-N1 |
9.119000E-01 |
|
|
